NASA Logo

NTRS

NTRS - NASA Technical Reports Server

Back to Results
Fluid ShiftsNASA is focusing on long-duration missions on the International Space Station (ISS) and future exploration-class missions beyond low-Earth orbit. Visual acuity changes observed after short-duration missions were largely transient, but more than 50% of ISS astronauts experienced more profound, chronic changes with objective structural and functional findings such as papilledema and choroidal folds. Globe flattening, optic nerve sheath dilation, and optic nerve tortuosity also are apparent. This pattern is referred to as the visual impairment and intracranial pressure (VIIP) syndrome. VIIP signs and symptoms, as well as postflight lumbar puncture data, suggest that elevated intracranial pressure (ICP) may be associated with the spaceflight-induced cephalad fluid shifts, but this hypothesis has not been tested. The purpose of this study is to characterize fluid distribution and compartmentalization associated with long-duration spaceflight, and to correlate these findings with vision changes and other elements of the VIIP syndrome. We also seek to determine whether the magnitude of fluid shifts during spaceflight, as well as the VIIP-related effects of those shifts, is predicted by the crewmember's preflight conditions and responses to acute hemodynamic manipulations (such as head-down tilt). Lastly, we will evaluate the patterns of fluid distribution in ISS astronauts during acute reversal of fluid shifts through application of lower body negative pressure (LBNP) interventions to characterize and explain general and individual responses. METHODS: We will examine a variety of physiologic variables in 10 long-duration ISS crewmembers using the test conditions and timeline presented in the Figure below. Measures include: (1) fluid compartmentalization (total body water by D2O, extracellular fluid by NaBr, intracellular fluid by calculation, plasma volume by CO rebreathe, interstitial fluid by calculation); (2) forehead/eyelids, tibia, calcaneus tissue thickness (by ultrasound); (3) vascular dimensions by ultrasound (jugular veins, cerebral and carotid arteries, vertebral arteries and veins, portal vein); (4) vascular dynamics by MRI (head/neck blood flow, cerebrospinal fluid pulsatility); (5) ocular measures (optical coherence tomography, intraocular pressure, 2-dimensional ultrasound including optic nerve sheath diameter, globe flattening, and retina-choroid thickness, Doppler ultrasound of ophthalmic and retinal arteries, and veins); (6) cardiac variables by ultrasound (inferior vena cava, tricuspid flow and tissue Doppler, pulmonic valve, stroke volume, right heart dimensions and function, four-chamber views); and (7) ICP measures (tympanic membrane displacement, distortion-product otoacoustic emissions, and ICP calculated by MRI). On the ground, acute head-down tilt will induce cephalad fluid shifts, whereas LBNP will oppose these shifts. Controlled Mueller maneuvers will manipulate cardiovascular variables. Through interventions applied before, during, and after flight, we intend to fully evaluate the relationship between fluid shifts and the VIIP syndrome.
Document ID
20150021479
Acquisition Source
Johnson Space Center
Document Type
Conference Paper
Authors
Stenger, M.
(Wyle Science, Technology and Engineering Group Houston, TX, United States)
Hargens, A.
(California Univ. San Diego, CA, United States)
Dulchavsky, S.
(Henry Ford Hospital Detroit, MI, United States)
Ebert, D.
(Wyle Science, Technology and Engineering Group Houston, TX, United States)
Lee, S.
(Wyle Science, Technology and Engineering Group Houston, TX, United States)
Lauriie, S.
(Wyle Science, Technology and Engineering Group Houston, TX, United States)
Garcia, K.
(Wyle Science, Technology and Engineering Group Houston, TX, United States)
Sargsyan, A.
(Wyle Science, Technology and Engineering Group Houston, TX, United States)
Martin, D.
(Wyle Science, Technology and Engineering Group Houston, TX, United States)
Ribeiro, L.
(Wyle Science, Technology and Engineering Group Houston, TX, United States)
Lui, J.
(California Univ. San Diego, CA, United States)
Macias, B.
(Wyle Science, Technology and Engineering Group Houston, TX, United States)
Arbeille, P.
(Tours Univ. France)
Danielson, R.
(Universities Space Research Association Houston, TX, United States)
Chang, D.
(California Univ. San Diego, CA, United States)
Johnston, S.
(NASA Johnson Space Center Houston, TX, United States)
Ploutz-Snyder, R.
(Universities Space Research Association Houston, TX, United States)
Smith, S.
(NASA Johnson Space Center Houston, TX, United States)
Date Acquired
November 20, 2015
Publication Date
February 8, 2016
Subject Category
Aerospace Medicine
Report/Patent Number
JSC-CN-34859
Meeting Information
Meeting: 2016 Human Research Program Investigator''s Workshop
Location: Galveston, TX
Country: United States
Start Date: February 8, 2016
End Date: February 11, 2016
Sponsors: NASA Headquarters
Distribution Limits
Public
Copyright
Public Use Permitted.
No Preview Available